Analystreport

Esperion Therapeutics Inc (NASDAQ: ESPR) was given a new $73.00 price target on by analysts at Citigroup Inc. They now have a "buy" rating on the stock.

Esperion Therapeutics, Inc.  (ESPR) 
Last esperion therapeutics, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.esperion.com